tetradecanoylphorbol acetate has been researched along with cgp 53716 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchdunger, E; Lydon, NB; Mett, H; Meyer, T; Müller, M; Regenass, U; Zimmermann, J | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and cgp 53716
Article | Year |
---|---|
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Line, Transformed; Epidermal Growth Factor; Female; Fibroblast Growth Factor 2; Humans; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Oncogene Proteins v-sis; Oncogenes; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Retroviridae Proteins, Oncogenic; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |